KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Current Assets (2016 - 2025)

LifeMD (LFMD) has disclosed Current Assets for 14 consecutive years, with $51.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets fell 1.03% year-over-year to $51.8 million, compared with a TTM value of $51.8 million through Dec 2025, down 1.03%, and an annual FY2025 reading of $51.8 million, down 1.03% over the prior year.
  • Current Assets was $51.8 million for Q4 2025 at LifeMD, up from $41.1 million in the prior quarter.
  • Across five years, Current Assets topped out at $52.4 million in Q4 2024 and bottomed at $11.3 million in Q4 2022.
  • Average Current Assets over 5 years is $33.1 million, with a median of $35.3 million recorded in 2022.
  • The sharpest move saw Current Assets skyrocketed 1034.82% in 2021, then plummeted 74.82% in 2022.
  • Year by year, Current Assets stood at $44.9 million in 2021, then tumbled by 74.82% to $11.3 million in 2022, then skyrocketed by 276.65% to $42.6 million in 2023, then increased by 22.92% to $52.4 million in 2024, then dropped by 1.03% to $51.8 million in 2025.
  • Business Quant data shows Current Assets for LFMD at $51.8 million in Q4 2025, $41.1 million in Q3 2025, and $49.0 million in Q2 2025.